failure to respond or late response
on 10 Sep 2022
Last Applicant/ Owned by
350 N GLENDALE AVE STE B123
Glendale
CA
91206
Serial Number
88977779 filed on 25th Feb 2019
Registration Number
N/A
Correspondent Address
Thomas F. Zuber
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
The color(s) blue is/are claimed as a feature of the mark. Mentholated ointment for medical use, all of the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, all the foregoing not including any products noncompliant with the U.S. Food Drug and Cosmetic Act; Medicated skin oils, all of the foregoing containing CBD derived fRead More
Mentholated ointment for medical use, all of the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, all the foregoing not including any products noncompliant with the U.S. Food Drug and Cosmetic Act; Medicated skin oils, all of the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, all the foregoing not including any products noncompliant with the U.S. Food Drug and Cosmetic Act; Topical analgesics, all of the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, all the foregoing not including any products noncompliant with the U.S. Food Drug and Cosmetic Act; Analgesic balm, all of the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, all the foregoing not including any products noncompliant with the U.S. Food Drug and Cosmetic Act; Medicated skin creams and lotions, all of the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, all the foregoing not including any products noncompliant with the U.S. Food Drug and Cosmetic Act; medicated skin care preparations, all of the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, all the foregoing not including any products noncompliant with the U.S. Food Drug and Cosmetic Act; medicated herbal topical creams, gels, skin sprays, balms, liniment and ointments, all the foregoing for the relief of pain, all of the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, all the foregoing not including any products noncompliant with the U.S. Food Drug and Cosmetic Act; Topical gel for medical and therapeutic treatment of minor aches and pains of muscles and joints, all of the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, all the foregoing not including any products noncompliant with the U.S. Food Drug and Cosmetic Act; Herbal tinctures for medical purposes, all of the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, all the foregoing not including any products noncompliant with the U.S. Food Drug and Cosmetic Act; Orally-ingestible herbal tinctures for medicinal purposes in the nature of nutritional and dietary supplements, all of the foregoing containing only naturally-occurring levels of CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, all the foregoing not including any products noncompliant with the U.S. Food Drug and Cosmetic Act; Medicated oral spray for pain, all of the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, all the foregoing not including any products noncompliant with the U.S. Food Drug and Cosmetic Act; Pharmaceutical, medicinal, medicated herbal, medicated botanical, and medicated preparations in the form of salves, concentrates, pastes, extracts, tinctures, and mucous membrane doses, for use in connection with pain, muscle tension, muscle spasms, and gastrointestinal illness, all of the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, all the foregoing not including any products noncompliant with the U.S. Food Drug and Cosmetic Act; Specialized tablets, capsules and powders for the delivery of pharmaceuticals sold without the pharmaceutical ingredient, all of the foregoing containing no cannabis and no cannabinoids, all the foregoing not including any products noncompliant with the U.S. Food Drug and Cosmetic Act; Muscle soaks, all of the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, all the foregoing not including any products noncompliant with the U.S. Food Drug and Cosmetic Act
No 88977779
No Service/Collective Mark
No 2869-1026
No
No
No
No
No
No
No
No
05.03.25 -
Other leaves
05.07.02 -
Clusters and sheaves of other grains, including stalks of grains
24.17.14 -
Punctuation marks, including commas(,), question marks(?), exclamation points(!¡), ampersands(&), at symbols(@), and hyphens(-)
26.01.01 -
Circles as carriers or as single line borders
The mark consists of a blue ampersand sitting inside a blue outline of a circle with a narrow blue leaf running through the ampersand. The white in the drawing is for background areas only and is not a feature of the mark.
Status Date | Action Taken |
---|---|
12th Sep 2022 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
10th Sep 2022 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
10th Sep 2022 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND |
11th Feb 2022 | SUBSEQUENT FINAL REFUSAL WRITTEN |
11th Feb 2022 | SUBSEQUENT FINAL EMAILED |
11th Feb 2022 | NOTIFICATION OF SUBSEQUENT FINAL EMAILED |
29th Sep 2021 | DIVISIONAL PROCESSING COMPLETE |
24th Sep 2021 | TEAS REQUEST TO DIVIDE RECEIVED |
24th Sep 2021 | DIVISIONAL REQUEST RECEIVED |
05th Jun 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |